PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake

Radiographics

Volumn 24, Issue 5, 2004, Pages 1411-1431

  Kostakoglu, Lale ^a   Hardoff, Ruth ^b   Mirtcheva, Rosna ^a   Goldsmith, Stanley J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Computed tomography (CT), **.12112; Computed tomography (CT), utilization; Fluorine, radioactive; Positron emission tomography (PET),**.12163; Radionuclide imaging, in diagnosis of neoplasms, **.12163

Indexed keywords

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18;

ABDOMEN; ACCURACY; ARTICLE; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; FIBROSIS; FUNCTIONAL ANATOMY; HEAD; HUMAN; IMAGE ANALYSIS; IMAGING; MALIGNANT NEOPLASTIC DISEASE; MEASUREMENT; MEDICAL EXAMINATION; MEDICAL TECHNOLOGY; METABOLISM; NECK; PATHOLOGICAL ANATOMY; PELVIS; POSITRON EMISSION TOMOGRAPHY; THORAX; TUMOR LOCALIZATION;

EID: 4944249729     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/rg.245035725     Document Type: Article

References (27)

1. Wahl RL. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. J Nucl Med 1996; 37:1038-1041.
2. Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics 2003; 23:315-339.
3. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. RadioGraphics 1999; 19:61-77.
4. Goerres GW, von Schulthess GK, Hany TH. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions and in changes resulting from treatment. AJR Am J Roentgenol 2002; 179:1337-1343.
5. Kluetz PG, Meltzer CC, Villemenagne VL, et al. Combined PET/CT imaging in oncology: impact on patient management. Clin Positron Imaging 2000; 3:223-230.
6. Abdel-Dayem HM, Rosen G, El-Zeftawy H, et al. Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation. Clin Nucl Med 1999; 24:319-322.
7. Gordon BA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR Am J Roentgenol 1997; 169:1675-1680.
8. Kostakoglu L, Wong JC, Barrington SF, Cronin BF, Dynes AM, Maisey MN. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med 1996; 37:1771-1773.
9. Zhu Z, Chou C, Yen TC, Cui R. Elevated F-18 FDG uptake in laryngeal muscles mimicking thyroid cancer metastases. Clin Nucl Med 2001; 26: 689-691.
10. Stahl A, Dzewas B, Schwaiger M, Weber WA. Excretion of FDG into saliva and its significance for PET imaging. Nuklearmedizin 2002; 41:214-216.
11. Wang GJ, Cai L. Relatively low-dose cyclophosphamide is likely to induce apoptotic cell death in rat thymus through Fas/Fas ligand pathway. Mutat Res 1999; 427:125-133.
12. Hughes FM, Cidlowski JA. Glucocorticoid-induced thymocyte apoptosis: protease-dependent activation of cell shrinkage and DNA degradation. J Steroid Biochem Mol Biol 1998; 65:207-217.
13. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002; 29:1393-1398.
14. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J Nucl Med 2003; 44:170-176.
15. Himms-Hagen J. Brown adipose tissue thermogenesis: interdisciplinary studies. FASEB J 1990; 4:2890-2898.
16. Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996; 37:1127-1129.
17. Poole DC, Kindig CA, Behnke BJ. Effects of emphysema on diaphragm microvascular oxygen pressure. Am J Respir Crit Care Med 2001; 163: 1081-1086.
18. Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003; 30:288-295.
19. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002; 224:783-787.
20. Guan L, Dadparvar S, Reich P, et al. Unrecognized renal transplants as a potential source: of false-positive interpretation of FDG PET. Clin Nucl Med 2003; 28:655-657.
21. Chander S, Meltzer CC, McCook BM. Physiologic uterine uptake of FDG during menstruation demonstrated with serial combined positron emission tomography and computed tomography. Clin Nucl Med 2002; 27:22-24.
22. Townsend DW, Beyer T. A combined PET/CT scanner: the path to true image fusion. Br J Radiol 2002; 75:S24-S30.
23. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44: 1200-1209.
24. Charron M, Beyer T, Bohnen NN, et al. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 2000; 25:905-910.
25. Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schulthess GK. PET/CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 2002; 29: 351-360.
26. Beyer T, Antoch G, Blodgett T, Freudenberg LF, Akhurst T, Mueller S. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 2003; 30:588-596.
27. Wahl RL, Townsend DW, Meltzer CC, Von Schulthess GK, Fishman EK. CT/PET fusion imaging (abstr). Radiology 2002; 225(P):42.